Azenta, Inc. completed the sale of B Medical Systems S.à r.l. to Thelema S.à r.l. on July 1, 2026, for an aggregate purchase price of $63 million. The consideration consists of $28 million in cash and a $35 million secured term loan provided by Azenta Germany GmbH to Thelema. The vendor loan carries a 6.0% annual interest rate and matures three months after funding. The transaction is a related party deal, as Thelema is majority owned by Luc Provost, a Company Vice President and CEO of the acquired entity. The loan is secured by a first-priority pledge of 100% of B Medical's equity interests. Azenta provides life sciences tools and services.